Case Report: Clinical Responses to Tislelizumab as a First-Line Therapy for Primary Hepatocellular Carcinoma With B-Cell Indolent Lymphoma by Qijun Li, Yong Dong, Yubin Pan, Honglin Tang, Da Li

Get full text

Exosomes and their roles in the chemoresistance of pancreatic cancer by Yubin Pan, Honglin Tang, Qijun Li, Guangpeng Chen, Da Li

Get full text

A dual-specific CRISPR-Cas nanosystem for precision therapeutic editing of liver disorders by Xiaojie Xu, Honglin Tang, Jiajing Guo, Huhu Xin, Yuan Ping

Get full text

Inflammation conditional genome editing mediated by the CRISPR-Cas9 system by Tingting Yuan, Honglin Tang, Xiaojie Xu, Jingjing Shao, Gaojun Wu, Young-Chang Cho, Yuan Ping, Guang Liang

Get full text

Inflammation conditional genome editing mediated by the CRISPR-Cas9 system by Tingting Yuan, Honglin Tang, Xiaojie Xu, Jingjing Shao, Gaojun Wu, Young-Chang Cho, Yuan Ping, Guang Liang

Get full text

Glabridin Prevents Doxorubicin-Induced Cardiotoxicity Through Gut Microbiota Modulation and Colonic Macrophage Polarization in Mice by Keqing Huang, Yanzhuo Liu, Yanzhuo Liu, Honglin Tang, Miao Qiu, Miao Qiu, Chenhong Li, Chenfan Duan, Chenlong Wang, Jing Yang, Xiaoyang Zhou

Get full text

Membrane-camouflaged supramolecular nanoparticles for co-delivery of chemotherapeutic and molecular-targeted drugs with siRNA against patient-derived pancreatic carcinoma by Honglin Tang, Yanan Xue, Bowen Li, Xiaojie Xu, Fu Zhang, Jiajing Guo, Qijun Li, Tingting Yuan, Yuan Chen, Yubin Pan, Yuan Ping, Da Li

Get full text